Short Interest in Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) Increases By 406.3%

Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) was the recipient of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 8,100 shares, a growth of 406.3% from the December 15th total of 1,600 shares. Based on an average daily volume of 356,600 shares, the days-to-cover ratio is presently 0.0 days.

Enzon Pharmaceuticals Price Performance

OTCMKTS:ENZN traded down $0.00 during trading hours on Tuesday, reaching $0.13. 7,032 shares of the company were exchanged, compared to its average volume of 92,676. The firm has a market cap of $9.64 million, a price-to-earnings ratio of 13.00 and a beta of 0.27. The stock has a 50 day simple moving average of $0.12 and a 200 day simple moving average of $0.13. Enzon Pharmaceuticals has a 52-week low of $0.06 and a 52-week high of $0.24.

Enzon Pharmaceuticals Company Profile

Enzon Pharmaceuticals, Inc, together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.